创业公司·2026年5月29日·来源： Pr Newswire Apac
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
内容仅提供英文版本
BOSTON , May 29, 2026 /PRNewswire/ -- XtalPi (2228. HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical company DoveTree Medicines Unus Inc.
#xtalpi#dovetree medicines unus inc.#ind-enabling studies#advances#dynamic conformation precision modeling platform#strategic collaboration#receives#surerxn reaction prediction model
原文报道： Pr Newswire Apac我们不转载全文， 阅读原文 →
